Detection of IgE antibodies specific to honeybee or Vespula venoms is an important criterium firstly for the diagnosis of sensitization and secondly for the indication for a specific immunotherapy. Some authors recommend to postpone blood analysis after an insect sting for a certain time because circulating IgE antibodies might be consumed by the allergic reaction, which would result in a false–negative test outcome. We investigated IgE concentrations during the first weeks after an insect sting in 31 patients with an unequivocal history of an anaphylactic reaction after a honeybee (n = 13) or Vespula (n = 18) sting. Blood samples for analysis of specific IgE concentrations (CAP system, Pharmacia Diagnostics, Sweden) were collected within 2 weeks and 5±2 weeks after the insect sting. 12/13 patients with honeybee venom and 14/18 patients with Vespula venom sensitization had CAP classes 1 or higher within the first 2 weeks. Those 5 patients with CAP class 0 within the first 2 weeks had detectable IgE concentrations a few weeks later. We conclude that testing for specific IgE to hymenoptera venoms is in most cases useful even during the first 2 weeks after the hymenoptera sting. This allows early decisions on further diagnostic procedures and the therapeutic way to choose. Patients with no detectable IgE should, however, be retested after a few weeks.

Keywords:
Hymenoptera venom, Specific IgE, CAP, Anaphylaxis/ allergy
1.
Stieger M, Wüthrich B, Wyss S, Kopper E: Zur Klinik und Diagnostik der Bienengiftallergie. Hautarzt 1978;29:632–636.
2.
Przybilla B, Ring J, Wielgosch J: Der Basophilen–Histamin–Freisetzungstest als diagnostische Methode bei Hymenopterengift–Allergie. Hautarzt 1988;39:662–670.
3.
Müller U: Klinik, Diagnose und Therapie der Insektenstichallergie. Schweiz Med Wochenschr 1989;49:1761–1768.
4.
Schlenvoigt G, Müller M, Jäger L, Wenz W: In–vitro–Untersuchungen zum Auftreten von Doppelsensibilisierungen und ihre Charakterisierung bei Insektengiftallergikern. Allergologie 1996;19:461–464.
5.
Przybilla B, Ring J: Hyposensibilisierungsbehandlung der Hymenopterengiftallergie: Aspekte der Indikationsstellung und Dosierung. Allergologie 1986;9:2–10.
6.
Settipane GA, Carlisle CC: A critical evaluation of RAST to venoms of hymenoptera. Clin Allergy 1980;10:667–673.
7.
Heinig JH, Engel T, Weeke ER: Allergy to venom from bee or wasp: The relation between clinical and immunological reactions to insect stings. Clin Allergy 1988;18:71–78.
8.
Goldberg A, Confino–Cohen R: Timing of venom skin tests and IgE determinations after insect sting anaphylaxis. J Allergy Clin Immunol 1997;100:182–184.
9.
Ring J, Messmer K: Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1977;i:466–468.
10.
Müller UR: Insektenstichallergie. Klinik, Diagnostik and Therapie. Jena, Fischer, 1988, p 78.
11.
Aberer W, Kränke B, Hager A, Wick G: In vitro allergy testing needs better standardization – Test results from different laboratories lack comparability mostly due to missing effective standards. Int Arch Allergy Immunol 1995;108:82–88.
1999
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.